The Alzheimer's drug bapineuzumab failed miserably in one of the biggest Phase III studies of the year. But the drug--once a megablockbuster hopeful at Johnson ...
I was not surprised to learn about the failure of bapineuzumab, the drug Pfizer, Johnson & Johnson, and Elan were developing as a treatment for Alzheimer's disease. Alzheimer's is a VERY difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback